FDA Enforcement
Class II
Terminated
Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.
Recall: Z-1338-2019
·
Reported May 22, 2019
Enforcement
- Recall Number
- Z-1338-2019
- Event ID
- 82653
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Integra Limited
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- May 22, 2019
- Initiation Date
- March 31, 2019
- Classification Date
- May 15, 2019
- Termination Date
- May 7, 2020
- Address
- 311 Enterprise Dr, Plainsboro, NJ, 08536-3344, United States
Description
Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.
Reason
Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months
Code Info
Lot Code: 2991332
Distribution
Worldwide Distribution - US Nationwide Foreign; Peru, Ecuador, Columbia, Brazil
Quantity
274 units